DE LUCA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 12.736
EU - Europa 11.518
AS - Asia 6.548
SA - Sud America 1.476
Continente sconosciuto - Info sul continente non disponibili 773
AF - Africa 150
OC - Oceania 6
Totale 33.207
Nazione #
US - Stati Uniti d'America 12.401
RU - Federazione Russa 3.234
IE - Irlanda 2.799
SG - Singapore 1.901
CN - Cina 1.726
DE - Germania 1.534
HK - Hong Kong 1.201
UA - Ucraina 1.116
BR - Brasile 1.085
SE - Svezia 1.030
VN - Vietnam 912
FI - Finlandia 546
FR - Francia 483
IT - Italia 299
IN - India 259
GB - Regno Unito 217
CA - Canada 178
AR - Argentina 138
ID - Indonesia 88
MX - Messico 76
BD - Bangladesh 73
KR - Corea 65
EC - Ecuador 63
CO - Colombia 57
ZA - Sudafrica 52
IR - Iran 50
PL - Polonia 49
NL - Olanda 44
IQ - Iraq 41
PY - Paraguay 41
VE - Venezuela 39
JP - Giappone 35
ES - Italia 32
TR - Turchia 29
AT - Austria 28
PK - Pakistan 26
MA - Marocco 22
CL - Cile 21
JM - Giamaica 20
BE - Belgio 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 17
PE - Perù 16
PH - Filippine 15
KZ - Kazakistan 13
LT - Lituania 13
TN - Tunisia 13
EU - Europa 12
HN - Honduras 12
IL - Israele 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
KE - Kenya 11
RO - Romania 11
EG - Egitto 10
GT - Guatemala 10
TH - Thailandia 10
UY - Uruguay 10
UZ - Uzbekistan 10
JO - Giordania 9
TT - Trinidad e Tobago 9
BJ - Benin 8
CR - Costa Rica 7
EE - Estonia 6
AZ - Azerbaigian 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
AL - Albania 4
HU - Ungheria 4
MD - Moldavia 4
NI - Nicaragua 4
SV - El Salvador 4
AM - Armenia 3
AU - Australia 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
BW - Botswana 3
BY - Bielorussia 3
GP - Guadalupe 3
GR - Grecia 3
HR - Croazia 3
KG - Kirghizistan 3
NG - Nigeria 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
KW - Kuwait 2
LC - Santa Lucia 2
LV - Lettonia 2
Totale 32.415
Città #
Dublin 2.799
Jacksonville 1.920
San Jose 1.454
Hong Kong 1.197
Dearborn 1.051
Singapore 758
Wilmington 702
Ashburn 626
Council Bluffs 620
Moscow 481
Beijing 463
Princeton 384
Lawrence 383
Lauterbourg 342
Ho Chi Minh City 302
San Mateo 261
Chandler 254
Los Angeles 246
Hanoi 178
Columbus 169
Ann Arbor 168
Bremen 165
Andover 163
Phoenix 163
Buffalo 160
Santa Clara 130
New York 108
São Paulo 104
Dallas 101
Houston 86
Hefei 74
Redondo Beach 70
Düsseldorf 67
Nanjing 66
Seoul 63
Orem 61
Norwalk 58
Guangzhou 51
Woodbridge 51
Kunming 50
Munich 49
Tianjin 47
Denver 46
Toronto 45
Rio de Janeiro 44
Haiphong 43
Atlanta 41
Piemonte 40
North Bergen 38
Fairfield 37
Frankfurt am Main 37
Montreal 37
Nuremberg 37
Jinan 36
Leawood 36
Da Nang 35
Warsaw 35
Chicago 34
Helsinki 34
Monmouth Junction 33
Seattle 33
Brooklyn 32
Chennai 32
Hangzhou 31
Johannesburg 30
Manchester 30
Tokyo 30
Mexico City 29
Rome 27
Biên Hòa 25
Shanghai 25
Amsterdam 23
Ardabil 22
Boston 22
Nanchang 22
Guayaquil 21
Poplar 21
Quito 21
Shenzhen 21
London 20
Philadelphia 20
San Francisco 20
Stockholm 20
Torino 20
Brussels 18
Brasília 17
Brno 17
Milan 17
Belo Horizonte 16
Boardman 16
Bắc Ninh 16
Campinas 16
Dong Ket 16
Hebei 16
Hải Dương 16
Jakarta 16
Bogotá 15
Curitiba 15
Guarulhos 15
Las Vegas 15
Totale 18.187
Nome #
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 158
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 147
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 147
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 144
Mechanical reperfusion for STEMI: from randomized trials to clinical practice 138
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 138
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 138
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 137
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 135
P2Y12 inhibitors: pharmacologic mechanism and clinical relevance 135
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 134
Coronary intravascular ultrasound (IVUS): Contemporary applications and bases for the future 134
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 133
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 132
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 132
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 132
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 131
ACC/AHA and ESC guidelines 131
PCI techniques 131
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans 131
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 131
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 131
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 130
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. 129
Switching from clopidogrel to prasugrel in patients having coronary stent implantation. 129
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 129
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 129
Apical-sparing Tako-tsubo: A case report 127
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 127
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 126
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 126
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 125
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 125
Adjuncitve pharmacotherapy: Anticoagulation 124
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 124
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 124
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. 124
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 124
Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. 123
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 123
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 123
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials 122
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 122
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 122
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 122
An unusual case of ECG ST-segment elevation 121
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. 121
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. 121
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 121
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 121
Long-term outcome of drug-eluting stents compared with bare metal stents in st-segment elevation myocardial infarction results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (paseo) randomized trial (Retraction in: Circulation (2010) 121:8 (e228)) 121
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 120
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 119
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. 119
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. 119
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study. 118
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 118
Antithrombotic therapies in primary angioplasty:rationale, results and future directions 118
Preprocedural β-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio 118
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 117
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 117
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 116
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. 116
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 116
A meta-analytic overview of thrombectomy during primary angioplasty 114
Redefining the success of mechanical reperfusion: ST-segment resolution 113
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 113
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 113
Impact of Preprocedural TIMI Flow on Myocardial Perfusion, Distal Embolization and Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Angioplasty and Glycoprotein IIb/IIIa Inhibitors 113
Update on prevention of infections in patients without spleen or with diminished splenic function. 112
Pharmacological facilitation in primary angioplasty: myth or reality? 111
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 111
Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment 111
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 111
Direct coronary stenting: Effects on coronary blood flow, immediate and late clinical outcome 110
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention. 110
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 110
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 110
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 109
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 109
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 108
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 108
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 108
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 108
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. 108
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 105
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 105
Immature platelet fraction and the extent of coronary artery disease: A single centre study 105
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 105
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 104
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention 104
Left ventricular angiography and other angiocardiographic techniques 103
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 103
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 103
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. 102
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 102
Mechanical prevention of distal embolization: Rationale and trial results 102
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 102
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 102
Impact of diabetes mellitus on immature platelet fraction and its association with coronary artery disease 102
Totale 12.005
Categoria #
all - tutte 185.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.655 0 0 0 135 200 8 163 35 155 60 385 514
2022/20234.395 412 147 211 54 246 262 81 193 2.640 8 87 54
2023/20241.236 65 71 78 18 279 2 225 20 3 9 188 278
2024/20252.968 55 29 98 21 70 387 280 234 936 350 62 446
2025/202611.363 364 374 1.088 1.920 737 819 1.866 1.999 743 788 519 146
2026/20272.958 343 904 923 788 0 0 0 0 0 0 0 0
Totale 33.207